UC Davis Health
UC Davis MIND Institute
Showmenu

Publications | Translational Psychophysiology and Assessment Laboratory | UC Davis MIND Institute

Publications

Translational Psychophysiology and Assessment Laboratory (T-PAL)

  1. Hessl D, Wang JY, Espinal GE, Santos E, Tassone F, Hagerman RJ & Rivera SM (2025). Longitudinal analysis of neuroradiological biomarkers for Fragile X-Associated Tremor/Ataxia Syndrome and implications for clinical trials. Annals of Neurology. https://doi.org/10.1002/ana.27267.
  2. Dakopolos A, Condy E, Smith E, Harvey D, Kaat AJ, Coleman J, Riley K, Berry-Kravis E, & Hessl D (2024). Developmental associations between cognition and adaptive behavior in intellectual and developmental disability. Journal of Neurodevelopmental Disorders 16, 31 (2024). https://doi.org/10.1186/s11689-024-09542-z
  3. Hessl D, Rojas KM, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman RJ, Tassone F, & Rivera SM (2023). FMR1 carriers report executive function changes prior to fragile X-associated tremor/ataxia syndrome: A longitudinal study. Movement Disorders 14(1): 1-10.
  4. Dakopolos A, Glassman D, Scott H, Bass M, & Hessl D (2023). iBehavior—a preliminary proof of concept study of a smartphone-based tool for the assessment of behavior change in neurodevelopmental disabilities. Frontiers in Psychology 14: doi.org/10.3389/fpsyg.2023.1217821.
  5. Tassone F, Protic D, Allen EG, Archibald AD, Baud A, Brown TW, Budimirovic DB, Cohen J, Dufour B, Eiges R, Elvassore N, Gabis LV, Grudzien SJ, Hall DA, Hessl D, Hogan A, Hunter JE, Jin P, Jiraanont P, Klusek J, Kooy RF, Kraan CM, Laterza C, Lee A, Lipworth K, Losh M, Loesch D, Lozano R, Mailik MR, Manolopoulos A, Martinez-Cerdeno V, McLennan Y, Miller RM, Montanaro FAM, Mosconi MW, Potter SN, Raspa M, Rivera SM, Shelly K, Todd PK, Tutak K, Wang JY, Wheeler A, Winarni TI, Zafarullah M, & Hagerman RJ (2023). Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. Cells; 12(18):2330. https://doi.org/10.3390/cells12182330
  6. Talapatra D, Snider L, Coleman J, Thompson T, Reinhardt JS, Hessl D, & Riley K (2023). Deviation scores: An innovative approach to interpreting cognitive test results for individuals with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities. 2023 Aug 8.
  7. Shields R, Kaat A, Sansone S, Michalak C, Coleman J, Thompson T, McKenzie F, Dakopolos A, Riley K, Berry-Kravis E, Widaman K, Gershon R, & Hessl D (2022). Sensitivity of the NIH Toolbox to detect cognitive change in individuals with intellectual and developmental disability. Neurology, 100(8), e778-e789.
  8. Hessl D, Rosselot H, Miller R, Espinal G, Famula J, Sherman SL, Todd PK, Herrera AMC, Lipworth K, Cohen C, Hall DA, Leehey M, Grigsby J, Dixon-Weber J, Alusi S, Wheeler A, Raspa M, Hudson T & Sobrian S (2022). The International Fragile X Premutation Registry: Building a resource for research and clinical trial readiness. Journal of Medical Genetics 59(12):1165-1170. doi: 10.1136/jmedgenet-2022-108568.
  9. McLennan YL, Mosconi MW, McKenzie FJ, Famula J, Krawchuck B, Kim K, Clark CJ, Hessl D, Rivera SM, Simon TJ, Tassone F, & Hagerman RJ (2022). Prosaccade and antisaccade paradigms in Fragile X-associated Tremor/Ataxia Syndrome progression. Movement Disorders Clinical Practice 9(4): 473-478.
  10. Famula J, Ferrer E, Hagerman RJ, Tassone F, Schneider A, Rivera SM, & Hessl D (2022) Neuropsychological changes in FMR1 premutation carriers and onset of Fragile X-Associated Tremor/Ataxia Syndrome. Journal of Neurodevelopmental Disorders 14: 23.
  11. Kaat AJ, McKenzie FJ, Shields RH, LaForte E, Coleman J, Michalak C & Hessl D (2021). Assessing processing speed among individuals with intellectual and developmental disabilities: A match-to-sample paradigm. Child Neuropsychology, DOI: 10.1080/09297049.2021.1938987.
  12. Hessl D, Libero L, Schneider A, Kerns C, Winder-Patel, Heath B, Lee J, Coleman C, Sharma N, Solomon M, Nordahl CW, & Amaral DG (2021). Fear potentiated startle in children with autism spectrum disorder: Association with anxiety symptoms and amygdala volume. Autism Research 14(3), 450-463.
  13. Shields R, Kaat A, McKenzie F, Drayton A, Sansone S, Coleman J, Michalak C, Riley K, Berry-Kravis E, Gershon R, Widaman K & Hessl D (2020).  Validation of the NIH Toolbox Cognitive Battery in Intellectual Disability.  Neurology (94), e1229-e1240.
  14. Hessl D, Schweitzer JB, Nguyen DV, McLennan YA, Johnston C, Shickman R & Chen Y (2019).  Cognitive training for fragile X syndrome: A randomized controlled trial of Cogmed.  Journal of Neurodevelopmental Disorders 11(4).
  15. Hessl D, Harvey C, Sansone S, Crestodina C, Chin J, Joshi R, Hagerman RJ, & Berry-Kravis E (2019). Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in fragile X syndrome.  PLOS One 14(1).